Literature DB >> 2023265

Multidrug resistance in acute myeloid leukemia.

M R Baer, C D Bloomfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2023265     DOI： 10.1093/jnci/83.10.663

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.

Authors:  Peter Schellongowski; Thomas Staudinger; Michael Kundi; Klaus Laczika; Gottfried J Locker; Andja Bojic; Oliver Robak; Valentin Fuhrmann; Ulrich Jäger; Peter Valent; Wolfgang R Sperr
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

Review 2.  Multidrug resistance in cancer chemotherapy.

Authors:  N H Patel; M L Rothenberg
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

Review 3.  Treatment concepts for elderly patients with acute myeloid leukemia.

Authors:  Wolfgang R Sperr; Alexander W Hauswirth; Friedrich Wimazal; Paul Knöbl; Klaus Geissler; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

4.  Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.

Authors:  J Schröder; M Esteban; M R Müller; S Kasimir-Bauer; U Bamberger; A Heckel; S Seeber; M E Scheulen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.

Authors:  H Shinoda; H Ebisu; J Mitsuhashi; M Inaba; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression.

Authors:  M R Müller; K Lennartz; C Boogen; M R Nowrousian; M F Rajewsky; S Seeber
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

7.  Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.

Authors:  M G Côme; A Skladanowski; A K Larsen; G Laurent
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells.

Authors:  Maya S Nair; Ullas Mony; Deepthy Menon; Manzoor Koyakutty; Neeraj Sidharthan; Keechilat Pavithran; Shantikumar V Nair; Krishnakumar N Menon
Journal:  Int J Nanomedicine       Date:  2015-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.